Paasa Logo
Tvardi Therapeutics, Inc. logo
TVRDNASDAQMarket openCloses 4:00pm ET

Tvardi Therapeutics, Inc.

$1.11Last updated
+$0.05 (4.25%)Past day
Timezone

Tvardi Therapeutics, Inc. (NASDAQ: TVRD) is trading at $1.11, about ₹106 at today's USD/INR rate, as of 25 Sep 2026, 11:46 AM ET, up 4.25% today. Indian residents can buy Tvardi Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$1.14
Previous close:$1.06
Volume:200.76K

Today's low

$1.10

Today's high

$1.16

52 week low

$0.93

52 week high

$43.65

TVRD opened at $1.14, closed previously at $1.06, and has traded between $0.93 and $43.65 over the past 52 weeks.

About

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.

Country
US
CEO
Imran Alibhai
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
12
Sector
Healthcare
IPO date
31/01/2014

Key statistics

Avg. volume

2.17M

Market cap

$10.37M

P/E Ratio

-0.40

Price-to-sales ratio

0.00

Enterprise value

-$5.25M

Free cash flow yield

-241.44%

Debt-to-equity ratio

0.02

Return on equity

-145.40%

ROIC

-319.05%

Beta

0.39

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$0.00

Earnings per share

-$2.46

Free cash flow

-$23.50M

Net profit margin

0.00%

Gross margin

0.00%

EBITDA

-$18.12M

Revenue growth

-100.00%

Similar securities

This is not an investment recommendation

How to buy Tvardi Therapeutics from India

Indian residents can buy Tvardi Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Tvardi Therapeutics and place an order

    Find Tvardi Therapeutics by name or by its ticker, TVRD, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Tvardi Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Tvardi Therapeutics position in USD and INR. Tvardi Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Tvardi Therapeutics from India

Trading and taxes when buying Tvardi Therapeutics from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneTvardi Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Tvardi Therapeutics stock?

Yes. Tvardi Therapeutics (TVRD) has been listed on NASDAQ since 2014, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Tvardi Therapeutics share cost in rupees?

One Tvardi Therapeutics share is $1.11 — about ₹106 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the Tvardi Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Tvardi Therapeutics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Tvardi Therapeutics?

Yes. One Tvardi Therapeutics share is $1.11, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Tvardi Therapeutics.

How are gains on Tvardi Therapeutics shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Tvardi Therapeutics price. Paasa issues a capital-gains statement for your return.

Does Tvardi Therapeutics pay a dividend?

No. Tvardi Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Tvardi Therapeutics from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Tvardi Therapeutics shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Tvardi Therapeutics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Tvardi Therapeutics holding, its cost and its closing value.

How do I sell Tvardi Therapeutics and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.